BostonGene powers an AI model of tumor and immune biology to deliver disease-level insights and enable precision decision-making across oncology and immune-mediated diseases. By integrating genomic, transcriptomic, immune, and clinical data, BostonGene generates biologically grounded intelligence to optimize patient selection, trial design, and therapeutic strategy, helping biopharma and academic partners accelerate precision therapies and improve clinical outcomes.